Skip to content

Australian patent for PromarkerEndo

 

Proteomics International secures Australian patent notice of acceptance for endometriosis innovative diagnostic test

  • IP Australia has provided a notice of acceptance for a patent protecting the PromarkerEndoproprietary blood test for the diagnosis of endometriosis

  • Major milestone with patent granted in PIQs local healthcare market

  • The patent supports commercialisation efforts and underpins the commercialisation pathway,enabling future partnerships and licensing opportunities.

  • Published clinical data has demonstrated the patented blood test has high accuracy fordiagnosing endometriosis, including in the early stages of the disease

  • Patent protection for the PromarkerEndo technology has now advanced in major jurisdictionsincluding Japan, the United States and Australia

  • Global need - endometriosis affects one in nine women and currently diagnosis typically takes anaverage of 7 years

 

View ASX Announcement: here
, , ,